De-risking Diabetes Drug Development to be Presented by KineMed, Inc.’s Dr. Marc Hellerstein at the 2012 Metabolic Leaders’ Forum
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that Dr. Marc Hellerstein, MD, PhD, Co-Founder & Chairman of the Scientific Advisory Board, KineMed; Professor, UC Berkeley (Calloway Chair); Professor of Medicine UCSF, will present at the Metabolic Leaders’ Forum 2012 on March 12th, 9:30 AM at the Westin San Francisco located at 50 Third Street San Francisco, CA.